Advances in targeted therapies III Ann Rheum Dis 2001; 60 (Supplement 3 ): 1. doi:10.1136/ard.60.90003.iii1 [Extract] [Full text] [PDF] [Request Permissions]

	Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001) D E FURST, E C KEYSTONE, F C BREEDVELD, J R KALDEN, J S SMOLEN, C E ANTONI, G R BURMESTER, L J CROFFORD, and A KAVANAUGH Ann Rheum Dis 2001; 60 (Supplement 3 ): 2. doi:10.1136/ard.60.90003.iii2 [Extract] [Full text] [PDF] [Request Permissions]

	Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages B W Jones, K A Heldwein, T K Means, J J Saukkonen, and M J Fenton Ann Rheum Dis 2001; 60 (Supplement 3 ): 6. doi:10.1136/ard.60.90003.iii6 [Abstract] [Full text] [PDF] [Request Permissions]
	High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach B M J Foxwell, S Yoshimura, J Bondeson, F M Brennan, and M Feldmann Ann Rheum Dis 2001; 60 (Supplement 3 ): 13. doi:10.1136/ard.60.90003.iii13 [Abstract] [Full text] [PDF] [Request Permissions]
	Novel targets for interleukin 18 binding protein C A Dinarello Ann Rheum Dis 2001; 60 (Supplement 3 ): 18. doi:10.1136/ard.60.90003.iii18 [Abstract] [Full text] [PDF] [Request Permissions]
	Biology of TACE inhibition R C Newton, K A Solomon, M B Covington, C P Decicco, P J Haley, S M Friedman, and K Vaddi Ann Rheum Dis 2001; 60 (Supplement 3 ): 25. doi:10.1136/ard.60.90003.iii25 [Abstract] [Full text] [PDF] [Request Permissions]
	Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor F Van den Bosch, D Baeten, E Kruithof, F De Keyser, H Mielants, and E M Veys Ann Rheum Dis 2001; 60 (Supplement 3 ): 33. doi:10.1136/ard.60.90003.iii33 [Extract] [Full text] [PDF] [Request Permissions]
	Cytokine blockers in psoriatic arthritis P J Mease Ann Rheum Dis 2001; 60 (Supplement 3 ): 37. doi:10.1136/ard.60.90003.iii37 [Abstract] [Full text] [PDF] [Request Permissions]
	Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines P Greenberg Ann Rheum Dis 2001; 60 (Supplement 3 ): 41. doi:10.1136/ard.60.90003.iii41 [Extract] [Full text] [PDF] [Request Permissions]
	Role of cytokines in the innate immune response to intracellular pathogens S Stenger and M Röllinghoff Ann Rheum Dis 2001; 60 (Supplement 3 ): 43. doi:10.1136/ard.60.90003.iii43 [Extract] [Full text] [PDF] [Request Permissions]
	Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment? D van der Heijde Ann Rheum Dis 2001; 60 (Supplement 3 ): 47. doi:10.1136/ard.60.90003.iii47 [Abstract] [Full text] [PDF] [Request Permissions]
	"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate M C Hochberg, J K Tracy, and R H Flores Ann Rheum Dis 2001; 60 (Supplement 3 ): 51. doi:10.1136/ard.60.90003.iii51 [Extract] [Full text] [PDF] [Request Permissions]
	Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences H G Kraetsch, C Antoni, J R Kalden, and B Manger Ann Rheum Dis 2001; 60 (Supplement 3 ): 55. doi:10.1136/ard.60.90003.iii55 [Abstract] [Full text] [PDF] [Request Permissions]
	New treatment options in ankylosing spondylitis: a role for anti-TNF therapy J Sieper and J Braun Ann Rheum Dis 2001; 60 (Supplement 3 ): 58. doi:10.1136/ard.60.90003.iii58 [Extract] [Full text] [PDF] [Request Permissions]
	Matrix metalloproteinase inhibitors in rheumatic diseases D R Close Ann Rheum Dis 2001; 60 (Supplement 3 ): 62. doi:10.1136/ard.60.90003.iii62 [Abstract] [Full text] [PDF] [Request Permissions]
	The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages A K Kiemer and A M Vollmar Ann Rheum Dis 2001; 60 (Supplement 3 ): 68. doi:10.1136/ard.60.90003.iii68 [Abstract] [Full text] [PDF] [Request Permissions]
	Antagonising angiogenesis in rheumatoid arthritis P E C Brenchley Ann Rheum Dis 2001; 60 (Supplement 3 ): 71. doi:10.1136/ard.60.90003.iii71 [Extract] [Full text] [PDF] [Request Permissions]
	Oncostatin M in the anti-inflammatory response A F Wahl and P M Wallace Ann Rheum Dis 2001; 60 (Supplement 3 ): 75. doi:10.1136/ard.60.90003.iii75 [Abstract] [Full text] [PDF] [Request Permissions]
	Osteoprotegerin U Feige Ann Rheum Dis 2001; 60 (Supplement 3 ): 81. doi:10.1136/ard.60.90003.iii81 [Extract] [Full text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.